Both in Pharmaceuticals
Merck & Co. vs ABBVIE
Over the past year MRK returned +90.0% and ABBV returned +18.0%; their daily moves had a correlation of 0.46.
MRK +90.0% ABBV +18.0%Growth of $1, one year, split-adjusted
| Metric | MRK | ABBV |
|---|---|---|
| Price | $149.28 | $263.29 |
| Market cap | $368.30B | $465.26B |
| Today | +0.40% | −1.12% |
| 1 month | +0.6% | +3.1% |
| 6 months | +26.4% | +23.5% |
| Year to date | +41.8% | +15.2% |
| 1 year | +90.0% | +19.3% |
| Revenue growth (YoY) | +5.1% | +10.2% |
| Gross margin | 73.5% | 74.7% |
| Net margin | −8.0% | 21.3% |
| P/E (TTM) | 116.1× | 74.0× |
| Price / sales | 5.5× | 7.2× |
| Net cash | -$46.77B | -$64.25B |
| Dividend yield | 2.28% | 2.63% |
| Volatility (60d) | 33.1% | 21.3% |
| Short % of float | 1.4% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).